---
layout: default
title: Activated Charcoal Arctium Lappa Root Bos Taurus C
parent: 僅模型預測 (L5)
nav_order: 199
evidence_level: L5
indication_count: 0
---

# Activated Charcoal Arctium Lappa Root Bos Taurus C
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Homeopathic Complex: Evaluation Not Feasible

## One-Sentence Summary

This candidate is a 25-ingredient complex mixture containing botanical extracts, animal-derived substances, homeopathic components, and trace minerals — most likely a homeopathic or complex natural preparation.
The TxGNN model was **unable to generate any repurposing predictions**, as the pipeline could not map this multi-ingredient complex to a single DrugBank entity or knowledge graph node.
With **no clinical trial evidence, no literature linkage, and no regulatory record**, meaningful evaluation cannot be completed at this stage.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available — no regulatory approvals found |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only — in this case, no prediction at all) |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

This formula contains 25 distinct components spanning multiple pharmacological categories:

**Botanical / herbal ingredients**: Arctium lappa root, Cinnamon, Fagus sylvatica flowering top, Gentiana lutea root, Lycopodium clavatum spore, Malus pumila flower, Prunus cerasifera flower, Rumex crispus root, Scrophularia nodosa whole, Syzygium cumini seed

**Animal-derived components**: Bos taurus colostrum, Oyster shell calcium carbonate, Pork intestine, Sus scrofa pancreas, Sus scrofa stomach

**Mineral / elemental components**: Copper gluconate, Gold, Magnesium gluconate, Manganese gluconate, Potassium gluconate

**Homeopathic / reactive substances**: Activated charcoal, Colchicum autumnale bulb, Nitric acid, Silver nitrate, Water

The TxGNN knowledge graph operates at the level of single chemical entities linked to DrugBank IDs. A 25-component mixture with no unified DrugBank identifier cannot be represented as a single node in the graph, making prediction structurally impossible with the current pipeline.

Notably, several individual components — such as **Colchicum autumnale** (source of colchicine) and **Syzygium cumini** (used in traditional diabetes management) — do have individual pharmacological profiles, but the combined formulation as a whole has no mappable identity in the current system.

---

## Clinical Trial Evidence

Currently no related clinical trials registered for this multi-ingredient combination.

---

## Literature Evidence

Currently no related literature available for this combination as a unified entity.

---

## US Market Information

This product has no registered authorizations in the United States. The query returned zero records from the regulatory database.

---

## Safety Considerations

Please refer to the package insert for safety information.

> **Note**: One ingredient warrants specific attention even without a full safety assessment: **Colchicum autumnale** contains colchicine, which has a narrow therapeutic index and known toxicity at elevated doses (gastrointestinal toxicity, myelosuppression, neuromyopathy). If this product is to be evaluated further, the dose and bioavailability of colchicine-containing components must be clarified.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline was unable to generate any repurposing predictions because this 25-ingredient complex cannot be represented as a single knowledge graph entity. Without a prediction, there is no scientific basis to proceed with a repurposing evaluation under the current framework.

**To proceed, the following is needed:**

- **Identify the product category**: Confirm whether this is a homeopathic preparation, a dietary supplement, or a traditional medicine compound — each has a different regulatory pathway and evidence standard
- **Decompose and evaluate individually**: Run each pharmacologically active component (especially Colchicum autumnale, Syzygium cumini, Gentiana lutea) through TxGNN as standalone entities
- **Obtain the original product labeling**: Determine the intended indication, dosage, and manufacturer to establish a baseline
- **Assess the colchicine risk**: Quantify the colchicine content from Colchicum autumnale and determine whether it reaches pharmacologically active or toxic levels
- **Reconsider pipeline scope**: If this is a homeopathic product (sub-pharmacological dilutions), it falls outside TxGNN's intended use case and should be routed to a different evaluation framework
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

